Therapeutic aspects. Immunosuppression in established humoral responses.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000921:Antibody-Producing Cells / Q000187:drug effects; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000096:biosynthesis; D001324:Autoantigens; D001485:Basement Membrane / Q000276:immunology; D002645:Chickens; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007105:Immune Complex Diseases / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008466:Mechlorethamine / Q000627:therapeutic use; D009393:Nephritis / Q000188:drug therapy; D011817:Rabbits; D051381:Rats; D012756:Sheep
D000970:Antineoplastic Agents; D001323:Autoantibodies; D001324:Autoantigens; D007166:Immunosuppressive Agents; D008466:Mechlorethamine; D003520:Cyclophosphamide